CLINUVEL PHARMACEUTICALS LIMITED

7.84%

$12.93

Market Cap $648.0M

Healthcare Biotechnology

Clinuvel Pharmaceuticals Limited is a specialty pharmaceutical company. It is focused on... Clinuvel Pharmaceuticals Limited is a specialty pharmaceutical company. It is focused on developing and commercializing treatments for patients with genetic, metabolic, systemic, and life-threatening, acute disorders, as well as healthcare solutions for specialized populations. Its lead therapy, SCENESSE (afamelanotide 16mg), is approved for commercial distribution in Europe, the United States of America, Israel, and Australia as the first systemic photoprotective drug for the prevention of phototoxicity (anaphylactoid reactions and burns) in adult patients with erythropoietic protoporphyria (EPP). It has operations in Europe, Singapore, and the United States of America. It develops and manufactures NEURACTHEL (adrenocorticotropic hormone) in different formulations, to target neurological, endocrinological, and degenerative disorders. Its pharmaceutical product, PRENUMBRA, has been developed, and its use is to be expanded in the clinic from stroke to Parkinson's.More

ASX:AFP

Could this ASX stock become the next Pfizer? A look at AFT Pharmaceuticals (ASX:AFP). With biotech stocks broadly having a strong run in 2025, and with more of the year ahead, investors are still looking for stocks in the sector with room to run. Latest:...

Latest Threads

Tag

Subject

CUV

Ann: CLINUVEL preparing upgrade of ADR program, NASDAQ uplist

17:37

4.4K

17:37

Last post Melon felon!

4.4K

CUV

Ann: CLINUVEL Annual Results - Investor Webinar

08:38

1.4K

08:38

Last post LJSM

1.4K

CUV

We're at $12!

21/08/25

22K

21/08/25

Last post septic1

22K

CUV

THE CLINUVEL SHARE BUYBACK

2 3 4

21/08/25

192

84K

21/08/25

Last post sydneybhai

192

84K

CUV

Clinuvel and Pro Medicus side by side

20/08/25

24K

20/08/25

Last post SimpleJim

24K

CUV

STRIKE ON SHAREHOLDER BEHALF. End the Manipulation

19/08/25

16K

19/08/25

Last post SimpleJim

16K

CUV

Clinuvel Takeover

18/08/25

20K

18/08/25

Last post Melon felon!

20K

CUV

Good news - Ord Minnett starts coverage

12/08/25

7.3K

12/08/25

Last post Silverchair

7.3K

See All Discussions

Timeline

CLINUVEL preparing upgrade of ADR program, NASDAQ uplist
22 Aug 09:30	Share

CLINUVEL Annual Results - Investor Webinar
21 Aug 12:17	Share

Bioshares Biotech Summit presentation
07 Aug 09:24	Share

Presentation to BTIG Biotech Conference
30 Jul 12:06	Share

Notification of cessation of securities - CUV
02 Jul 08:21	Share

German Non-deal Roadshow Presentation
24 Jun 08:45	Share

Ceasing to be a substantial holder
19 Jun 08:16	Share

Study confirms NB-UVB needed to activate repigmentation
18 Jun 09:35	Share

Becoming a substantial holder
18 Jun 08:19	Share

CLINUVEL management update
13 Jun 09:35	Share

SCENESSE successfully administered to paediatric EPP patient
13 Jun 08:58	Share

SCENESSE in Vitiligo - A Global Update
04 Jun 10:07	Share

SCENESSE EPP data featured at EADV Symposium
22 May 08:57	Share

Ceasing to be a substantial holder
09 May 08:24	Share

CUV recruits 200 patients in Phase III vitiligo trial CUV105
07 May 08:41	Share

Notification regarding unquoted securities - CUV
23 Apr 09:00	Share

Notification of cessation of securities - CUV
09 Apr 08:22	Share

Section 708A Cleansing Statement
07 Apr 08:55	Share

Application for quotation of securities - CUV
07 Apr 08:51	Share

Application for quotation of securities - CUV
07 Apr 08:49	Share

Change in substantial holding
01 Apr 19:43	Share

Notification of buy-back - CUV
27 Mar 09:04	Share

CLINUVEL renews share buy-back program
27 Mar 09:03	Share

Update - Notification of buy-back - CUV
27 Mar 08:58	Share

Positive preliminary results for PRENUMBRA Instant in stroke
26 Mar 09:15	Share

2025 American Academy of Dermatology Annual Meeting
24 Mar 09:19	Share

CLINUVEL management update
18 Mar 09:02	Share

CLINUVEL Unveils Vitiligo Program for AAD 2025
04 Mar 08:59	Share

CLINUVEL Investor Webinar
28 Feb 09:06	Share

Chair Letter to Shareholders
28 Feb 09:04	Share

View More

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last $12.93		Change 0.940(7.84%)		Mkt cap ! $648.0M

Open	High	Low	Value	Volume
$12.05	$13.23	$11.96	$2.763M	215.6K

Buyers (Bids)

No.	Vol.	Price($)
1	2000	$12.88

Sellers (Offers)

Price($)	Vol.	No.
$13.00	300	1

View Market Depth

No.	Vol.	Price($)
1	2000	12.880
1	156	12.860
1	128	12.820
1	158	12.710
1	277	12.600

Price($)	Vol.	No.
13.060	500	1
13.080	500	1
13.100	65	1
13.150	300	1
13.170	76	1

Last trade - 16.10pm 22/08/2025 (20 minute delay)


Last $13.03		Change 0.940 ( 8.74 %)
Open	High	Low	Volume
$12.04	$13.19	$12.00	12428
Last updated 15.59pm 22/08/2025 ?

CUV (ASX) Chart

CLINUVEL PHARMACEUTICALS LIMITED

Latest Threads

Listen: HotCopper Wire Podcast 021 – The inexplicable Kaili Resources rocket

Timeline

Featured News

Latest Articles

Clinuvel shares dip, even as CEO comes back from temp leave

After Clinuvel's (ASX:CUV) CEO Dr. Philippe Wolgen took time off back in March to respond to an "acute medical condition," it wasn't...

Clinuvel stroke drug shows 'positive' results – but some adverse effects left unclear

Clinuvel shares jumped on Tuesday on higher volumes as the company reported a clinical trial win with its stroke drug, 'PRENUMBRA.'

British study shows Clinuvel drug effective on DNA of UV-damaged skin

Clinuvel Pharmaceuticals Ltd has reported final results of its study of the efficacy of afamelanotide to repair the DNA of damaged skin.

Buyers (Bids)

Sellers (Offers)

EV Resources executes strategic MOU with Wogen, XCLR to fund and advance Los Lirios antimony project

Top Stories

Featured News